From: Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania
Body weight (kg)
Daily dose (mg)
Number of tablets per dose
20/160 mg DHA/PQ
40/320 mg DHA/PQ
5-12
20/160 mg DHA/PQP
1
13-23
40/320 mg DHA/PQP
25-35
2
36-74
3
>74
4